Sponsored by:
Making the Change: How to prepare for the future of clinical trials?
Patient-facing digital technologies are playing an increasingly important role in clinical trials, to the point where including virtual components in trials has become mainstream.
But terms like remote, site-less, hybrid, and decentralized trials have added ambiguity and confusion to this new virtual ecosystem. Where exactly does the industry stand on terms like "virtual" or "decentralized" trials?
Advancements in technology have enabled virtual visits and remote patient monitoring and have provided new options for data collection. This has forged the path for hybrid and decentralized clinical trials. These new approaches improve patient experience, data quality, and expedite the clinical trial process. Studies are more accessible and convenient for patients. Investigators gain valuable patient insights, and sponsors get answers to their scientific questions faster.
However, moving in this direction requires change. Trying to incorporate new world innovations into a traditional protocol design and operational practices doesn’t fit. It’s not enough to choose a patient-facing technology, the entire data flow needs to be optimized. Consider the effect on data quality, healthcare professional workflow, patient ability to comply, and feasibility of conducting a trial across geographies.
The hesitancy to change is understandable given the potential impact on an organization. A deep understanding of what constitutes a hybrid or decentralized clinical trial is necessary in order to effectively determine if a shift is the right move.
Join this webinar to understand
- Hybrid and decentralized clinical trials
- What are the benefits and challenges of decentralized trials?
- What does the future hold for decentralized trials?
- Ways to optimize new clinical trial technologies
Who should attend?
- Clinical Research Coordinator
- Clinical Site Managers
- Data Manager
- Clinical Research Scientist
- Director Clinical Research
